Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Illuminating Depression: ipRGC as a Potential Biomarker for Predicting Transcranial Magnetic Stimulation Treatment Response in Major Depressive Disorder

NCT07474974 is registered in ClinicalTrials.gov with Polytechnic Institute of Porto as lead sponsor.

NCT NCT07474974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07474974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Illuminating Depression: ipRGC as a Potential Biomarker for Predicting Transcranial Magnetic Stimulation Treatment Response in Major Depressive Disorder
Lead sponsor
Polytechnic Institute of Porto
Phase
Not applicable
Overall status
Recruiting
Start date
March 15, 2026
Completion date
July 31, 2027
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression - major depressive disorder, treatment resistant depression